Articles From: UPDATE: Follow these three rules, and retire comfortably to UPDATE: Gilead earnings buoyed by Hepatitis-C drug


2014/5/9
By Philip van Doorn When making big financial decisions --
Sign-up for UPDATE: Follow these three rules, and retire comfortably investment picks
2014/5/20
By Marek Fuchs With the economy either wrapped in clover or caked in mud, all eyes on Tuesday will fall upon Home Depot, which reports first-quarter earnings.
Sign-up for UPDATE: For Home Depot's earnings -- well, it's complicated investment picks
NEW YORK (MarketWatch) -- Watchmaker Fossil Group Inc. (FOSL) shares fell 4.3% in after hours trading after the watch and accessories maker forecast second-quarter profit of 90 cents to 97 cents a share.
Sign-up for UPDATE: Fossil drops after weak second-quarter forecast investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Fossil Group Inc. shares declined in the extended session Tuesday after the fashion-accessories company followed up a quarterly earnings beat with a poor outlook for the current quarter.
Sign-up for UPDATE: Fossil, Take-Two shares fall on weak outlooks investment picks
SAN FRANCISCO (MarketWatch) -- Shares of Freddie Mac (FMCC) and Fannie Mae (FNMA) popped on Monday after Bill Ackman of Pershing Square Management characterized the two companies as essential to the U.S. mortgage market.
Sign-up for UPDATE: Freddie Mac, Fannie Mae up on Ackman presentation investment picks
2014/5/1
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- The U.K.'s FTSE 100 index advanced on Thursday after solid manufacturing and housing data, while well-received earnings reports from Lloyds Banking Group and BSkyB also helped an upbeat trading mood.
Sign-up for UPDATE: FTSE 100 climbs after strong housing, PMI data investment picks
2014/4/10
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K. stocks stayed mostly higher on Thursday after the Bank of England left monetary policy unchanged as expected.
Sign-up for UPDATE: FTSE 100 climbs for second after BOE rate decision investment picks
2014/4/10
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K. stocks stayed mostly higher on Thursday after the Bank of England left monetary policy unchanged as expected.
Sign-up for UPDATE: FTSE 100 climbs for second day after BOE rate decision investment picks
2014/5/6
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Barclays led the U.K.'s FTSE 100 lower on Tuesday after a weak earnings report, although most U.K. stocks advanced after better-than-expected data for the services sector.
Sign-up for UPDATE: FTSE 100 drops as Barclays loss outweighs solid PMI investment picks
2014/4/10
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- After a volatile trading day, U.K. stocks closed slightly higher on Thursday, with banks leading the advance after the Bank of England left monetary policy unchanged as expected.
Sign-up for UPDATE: FTSE 100 ekes out gain after BOE stands pat on rates investment picks
2014/5/7
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Experian led U.K. stocks to a small loss on Wednesday after pointing out a number of headwinds, although the benchmark index trimmed losses on an easing in Ukraine tensions in the afternoon.
Sign-up for UPDATE: FTSE 100 ends slightly lower as HSBC, Experian fall investment picks
2014/4/14
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K. stocks came off session lows Monday, with shares of Randgold Resources Ltd.
Sign-up for UPDATE: FTSE 100 slips, but Glencore Xstrata gains investment picks
2014/4/14
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K. stocks reversed course and finished higher Monday, with shares of Randgold Resources Ltd.
Sign-up for UPDATE: FTSE 100 turns higher as mining stocks strengthen investment picks
2014/5/22
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 index struggled for direction at the close on Thursday as shares of SABMiller rose after a well-received earnings report, while Royal Dutch Shell B shares slumped after a change in buyback programs.
Sign-up for UPDATE: FTSE 100 wavers as Shell outweighs SABMiller gain investment picks
2014/5/19
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- AstraZeneca PLC shares tumbled in London on Monday after the pharmaceutical maker rejected Pfizer Inc.'s increased takeover offer, while some mining firms declined on further signs of a slowdown in the Chinese housing market.
Sign-up for UPDATE: FTSE 100 yanked lower by AstraZeneca, miners investment picks
2014/5/19
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- AstraZeneca PLC shares tumbled in London on Monday after the pharmaceutical maker rejected Pfizer Inc.'s increased takeover offer, while mining firms declined on further signs of a slowdown in the Chinese housing market.
Sign-up for UPDATE: FTSE 100 yanked lower by AstraZeneca, miners investment picks
2014/4/19
By Dan Neil You think it's easy.
Sign-up for UPDATE: Fusion cuisine: Lincoln MKZ isn't a full meal investment picks
By Saumya Vaishampayan, MarketWatch NEW YORK (MarketWatch) -- Shares of GameStop Corp.
Sign-up for UPDATE: GameStop, FireEye rise; Aeropostale slumps investment picks
By Sue Chang and Ben Eisen, MarketWatch SAN FRANCISCO (MarketWatch) -- Gap Inc. rallied Friday after the firm gave an upbeat profit estimate, while Apple Inc. retreated on media reports that it is in talks to buy headphone maker Beats Electronics in a multi-billion dollar deal.
Sign-up for UPDATE: Gap gains on upbeat view; Apple falls on Beats news investment picks
NEW YORK (MarketWatch) -- Gap Inc. (GPS) shares fell as much as 5.8% on Friday to be the biggest decliner in the S&P 500 Index after the clothing retailer reported a disappointing 6% decline in its March same-store sales.
Sign-up for UPDATE: Gap is the No. 1 S&P 500 decliner investment picks
NEW YORK (MarketWatch) -- Gap Inc. (GPS) said on Thursday its fiscal first-quarter profit fell to $260 million, or 58 cents a share, from $333 million, or 71 cents, a year earlier, when it had a four-cent tax benefit.
Sign-up for UPDATE: Gap keeps full-year outlook as currency dents quarterly profit investment picks
NEW YORK (MarketWatch) -- Gap Inc. (GPS), which is seeking to gain share in the $1.4 trillion global apparel market, said on Wednesday at its annual investor meeting that China will be its largest growth initiative.
Sign-up for UPDATE: Gap plans to triple China sales to $1 billion in three years investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Gap Inc. shares surged in the extended session Thursday after the company topped analyst expectations for April same-store sales and forecast first-quarter earnings above the consensus.
Sign-up for UPDATE: Gap shares jump on sales; Apple dips on Beats deal investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Gap Inc. shares surged in the extended session Thursday after the company topped analyst expectations for April same-store sales and forecast first-quarter earnings above the consensus.
Sign-up for UPDATE: Gap shares surge on April sales, outlook investment picks
2014/4/24
NEW YORK (MarketWatch) - General Motors Co.
Sign-up for UPDATE: General Motors shares rise as profit tops forecast investment picks
By Sital S.
Sign-up for UPDATE: Genworth CEO sees opportunity in long-term care investment picks
2014/5/23
By Daniel Goldstein For more than 25 years during on Memorial Day weekend in Washington, D.C., the nation's capital has hosted the biggest motorcycle rally in honor of missing servicemen, known simply as Rolling Thunder.
Sign-up for UPDATE: Get on your hog: Harley-Davidson riders to honor vets investment picks
2014/5/24
By Daniel Goldstein For more than 25 years during on Memorial Day weekend in Washington, D.C., the nation's capital has hosted the biggest motorcycle rally in honor of missing servicemen, known simply as Rolling Thunder.
Sign-up for UPDATE: Get on your hog: Harley-Davidson riders to honor vets investment picks
SAN FRANCISCO (MarketWatch) -- Gilead Sciences Inc. (GILD) reported late Tuesday its first-quarter net income rose to $2.23 billion, or $1.33 per diluted share, from $722.2 million, or 43 cents per diluted share, a year earlier.
Sign-up for UPDATE: Gilead beats expectations; Sovaldi sales hit $2.3 bln investment picks
2014/4/22
By Anna Prior Gilead Sciences Inc. said sales of its new treatment for hepatitis C soared in the first quarter, helping the biopharmaceutical company's bottom-line to triple.
Sign-up for UPDATE: Gilead earnings buoyed by Hepatitis-C drug investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: UPDATE: Follow these three rules, and retire comfortably to UPDATE: Gilead earnings buoyed by Hepatitis-C drug
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry